Recursion Pharmaceuticals, Inc. reported raising $32 Million in an initial SEC Form D filing, from an offering of $32 Million
PUBLIC · RXRXSep 14, 2016
Amount Raised
$32 Million
$32 Million sold, per SEC Form D (first sale Sep 14, 2016)
Round Type
Venture
Salt Lake CityBiotechnologyHealthcareHealth CareArtificial IntelligenceTherapeuticsPharmaceuticalWho to call at Recursion Pharmaceuticals, and when
A new round usually means Recursion Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Recursion Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Recursion Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Recursion Pharmaceuticals. With Fundz connected, it knows.
Watch Fundz in
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Recursion Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
1 contact
Verified contacts53 people are listed at Recursion Pharmaceuticals. We don't have their email yet.See plans and pricing
Recursion Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.